Chee Kay Cheung

9PUBLICATIONS
47CO-AUTHORS
HaematologyNeural engineeringPodiatryImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 23, 2026
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? no.

Chee Kay Cheung, Jonathan Barratt

|Sep 23, 2025
How should we target and reduce the production of pathogenic IgA in IgAN?

Chee Kay Cheung, Yusuke Suzuki

|Oct 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.

Philipp Gauckler, Anna Matyjek, Seleni Kapsia

|Jul 01, 2024
The use of albuminuria or proteinuria for risk prediction in IgAN.

Chee Kay Cheung, Jonathan Barratt

|Oct 06, 2023
Targeting APRIL in the Treatment of IgA Nephropathy.

Chee Kay Cheung, Jonathan Barratt, Kevin Carroll

|Oct 29, 2022
The role of complement in glomerulonephritis-are novel therapies ready for prime time?

Chee Kay Cheung, John P Dormer, Jonathan Barratt

Pageof 2